InMode beat estimated earnings by 6.98%, reporting an EPS of $0.46 versus an estimate of $0.43. Revenue was up $6.05 million from the same period last year. In the previous quarter, the company beat ...

YOKNEAM, Israel, Feb. 2, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies ("InMode" or the "Company"), today issued the following statement ...

IRVINE, Calif., Nov. 3, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has appointed Michael Dennison, most recently Vice President of ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

YOKNEAM, Israel (AP) — YOKNEAM, Israel (AP) — InMode Ltd. (INMD) on Wednesday reported earnings of $26.7 million in its second quarter. On a per-share basis, the Yokneam, Israel-based company said it ...

InMode Australia today announces the launch of Triton, a Strategic Solution to help independent clinics and providers retain clients and compete with laser chains. This highly affordable ...

Investing.com - InMode Ltd . (NASDAQ:INMD) reported preliminary second-quarter revenue below analyst expectations and reduced its full-year guidance, while BTIG maintained its Neutral rating on the ...

YOKNEAM, Israel - InMode Ltd. (NASDAQ:INMD), a provider of medical technology currently valued at $919 million, responded to DOMA Perpetual Capital Management’s CEO Pedro Escudero regarding his ...

Barclays analyst Matt Miksic raised the firm’s price target on InMode (INMD) to $29 from $26 and keeps an Overweight rating on the shares post the Q4 report. The firm says the company delivered ...

I'm downgrading InMode from a 'Strong Buy' to a 'Buy' due to consistent guidance cuts and short-term demand issues. Despite recent performance issues and high interest rates, INMD still holds a strong ...